Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
- By Treatment Mode
5.1 Introduction
5.2 Endovenous Ablation
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Injection Sclerotherapy
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Surgical Ligation/Stripping
5.4.1 Market Overview
5.4.2 Market Size and Forecast
- By Product
6.1 Introduction
6.2 Ablation Devices
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Radiofrequency Ablation Devices
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Laser Ablation Devices
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Venous Closure Products
6.5.1 Market Overview
6.5.2 Market Size and Forecast
- By Geography
7.1 Introduction
7.2 Europe
7.2.1 Europe Market, By Treatment Mode
7.2.2 Europe Market, By Product
7.3 North America
7.3.1 North America Market, By Treatment Mode
7.3.2 North America Market, By Product
7.4 Asia Pacific
7.4.1 Asia Pacific Market, By Treatment Mode
7.4.2 Asia Pacific Market, By Product
7.5 Rest of The World
7.5.1 Rest of The World Market, By Treatment Mode
7.5.2 Rest of The World Market, By Product
- Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
- Company Profiles
9.1 Medtronic plc
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 AngioDynamics, Inc.
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Biolitec AG
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Syneron Medical Ltd.
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Lumenis Ltd.
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Dornier MedTech GmbH
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Energist Group
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Eufoton s.r.l.
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Vascular Solutions, Inc.
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Quanta System S.p.A.
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments